Every year some of the world’s most influential actors put their day-to-day business to the side and join colleagues in Davos, a mountain resort in the eastern Alps region of Switzerland. A picturesque setting, with plenty of enjoyable touristic activities, these folks however do not arrive to play. Rather, they’ve come together to attend the World Economic Forum (WEF), a meeting with a lofty mission – to improve the state of the world by engaging academic, political, and business leader to shape regional, global, and industry agendas.
The 2020 get-together was pre-pandemic, so Zoom was not the preferred communication medium. This was fortunate for Atai Life Sciences AG, a company experimenting with alternative drug rehabilitation. Backed by billionaire investor Peter Thiel, the company had quite possibly their most valued, captive audience to date, and one that most presumed could care less about the subject matter. Yet, the reception was incredible. Ibogaine and other psychedelics have proven their effectiveness, and getting that message out is now the current challenge. Eyk Henning explains in “A Hallucinogenic Root Is Pitched to Davos Set as Treatment for Opioid Addiction” how opioid and heroin rehabilitation, among others, are being completely re-thought with ibogaine.
Ibogaine treatment in Mexico has been advancing rapidly, especially in the area of fentanyl detox. Having world leaders with the clout and cache behind this movement could very well be a record breakthrough.
Read the full article here: https://www.bloomberg.com/news/articles/2020-01-22/hallucinogenic-root-takes-davos-stage-as-addiction-fighter